Onyx Scientific is expanding its GMP space for its small scale API manufacturing services.The company will install a new Class 100,000 suite at its facility in North East England to meet client needs for Phase I/II GMP campaigns. 
 
Onyx Scientific specializes in preclinical/clinical development projects and offers production of API up to 50l-100l under current GMP regulations, as well as earlier stage custom synthesis, lead optimization, solid state and analytical services.
 
Denise Bowser, commercial director at Onyx Scientific, said, “This latest investment will bring the total capacity at our UK site up to four dedicated GMP suites, which represents a steady but significant growth in this area over the past few years.Having an additional GMP suite at our disposal, it gives us even greater flexibility to assist our clients that are under increasing timeline pressure to deliver against their development programs.”